Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
News Archive
News Archive Navigation
News Archive Navigation Language
December 2014
-
Talking to: Juergen Brokatzky-Geiger, Global Head of Corporate Responsibility at Novartis
In October 2013, we created a new, full-time position to lead our CR efforts. Juergen Brokatzky-Geiger, formerly Global Head of Human Resources and a member of the Executive Committee, took on this role effective in February 2014.
-
A fresh look at fighting glaucoma
Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.
October 2014
-
Treating cataracts, a leading cause of preventable blindness worldwide
Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.
-
Biological battle of the bulge
John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.
-
10 big questions to dissect science papers
Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.
September 2014
-
No longer living in fear
This moving personal story about the challenges of living with a rare disease is written by Rocco Falchetto, a biochemist and director of analytical sciences and imaging at the Novartis Institutes for BioMedical Research (NIBR).
-
3-D printing: Scientists reinvent research tools
The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.
-
Dealing with the spread of chronic disease in Africa
Over the next 15 years chronic disease like cancer and heart disease will become major killers in Sub-Saharan Africa. A new report from the Economist Intelligence Unit explains why.
July 2014
-
New drugs could offer hope for malaria patients
In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.
-
Novartis scientists target resistance threat in malaria
Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.
Pagination
- ‹ Previous page
- 1
- …
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- › Next page
Test disclaimer...!!!